3 Drug Industry Challenges in Targeting Patient Value
Drug companies are getting better at targeting patient value.
In 2010, a drug company was working on new ways to differentiate their cancer drug (Drug 2) from the market leader (Drug 1).
Both drugs had
ValueVitals
